Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 2.22 and has seen 1.29 million shares traded in the last trading session. The PTPI stock price is -1825.0% off its 52-week high price of $0.77 and 0.0% above the 52-week low of $0.04. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.46 million shares traded. The 3-month trading volume is 35.83 million shares.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
Sporting 2.24% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PTPI stock price touched $0.04 or saw a rise of 17.7%. Year-to-date, Petros Pharmaceuticals Inc shares have moved -89.59%, while the 5-day performance has seen it change -13.87%. Over the past 30 days, the shares of Petros Pharmaceuticals Inc (NASDAQ:PTPI) have changed -42.90%. Short interest in the company has seen 1.48 million shares shorted with days to cover at 0.04.
Petros Pharmaceuticals Inc (PTPI) estimates and forecasts
The company’s shares have lost -86.55% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 55.46% over the past 5 years.
PTPI Dividends
Petros Pharmaceuticals Inc is expected to release its next earnings report on 2024-Nov-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Insiders own 6.01% of the company shares, while shares held by institutions stand at 4.86% with a share float percentage of 5.17%. Investors are also buoyed by the number of investors in a company, with Petros Pharmaceuticals Inc having a total of 12.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.06% shares in the company for having 31.81 shares of worth $1304.0 while later fund manager owns 34.65 shares of worth $1420.0 as of Feb 28, 2025 , which makes it owner of about 0.06% of company’s outstanding stock.
